293 related articles for article (PubMed ID: 19168602)
21. Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study.
Goodman AD; Cohen JA; Cross A; Vollmer T; Rizzo M; Cohen R; Marinucci L; Blight AR
Mult Scler; 2007 Apr; 13(3):357-68. PubMed ID: 17439905
[TBL] [Abstract][Full Text] [Related]
22. Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers.
Cicolin A; Magliola U; Giordano A; Terreni A; Bucca C; Mutani R
Epilepsia; 2006 Jan; 47(1):82-5. PubMed ID: 16417535
[TBL] [Abstract][Full Text] [Related]
23. Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary.
Dunteman ED
J Pain Palliat Care Pharmacother; 2005; 19(1):35-43. PubMed ID: 15814513
[TBL] [Abstract][Full Text] [Related]
24. Specific effect of levetiracetam in experimental human pain models.
Enggaard TP; Klitgaard NA; Sindrup SH
Eur J Pain; 2006 Apr; 10(3):193-8. PubMed ID: 15946871
[TBL] [Abstract][Full Text] [Related]
25. The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers.
Mitchell JM; Grossman LE; Coker AR; Messing RO
J Clin Psychopharmacol; 2012 Apr; 32(2):269-72. PubMed ID: 22367657
[TBL] [Abstract][Full Text] [Related]
26. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
[TBL] [Abstract][Full Text] [Related]
27. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
[TBL] [Abstract][Full Text] [Related]
28. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
Young W; Shaw J; Bloom M; Gebeline-Myers C
Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
[TBL] [Abstract][Full Text] [Related]
29. Levetiracetam in social phobia: a placebo controlled pilot study.
Zhang W; Connor KM; Davidson JR
J Psychopharmacol; 2005 Sep; 19(5):551-3. PubMed ID: 16166192
[TBL] [Abstract][Full Text] [Related]
30. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome.
Awaad Y; Michon AM; Minarik S
Mov Disord; 2005 Jun; 20(6):714-8. PubMed ID: 15704204
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.
Conte A; Bettolo CM; Onesti E; Frasca V; Iacovelli E; Gilio F; Giacomelli E; Gabriele M; Aragona M; Tomassini V; Pantano P; Pozzilli C; Inghilleri M
Eur J Pain; 2009 May; 13(5):472-7. PubMed ID: 18603457
[TBL] [Abstract][Full Text] [Related]
32. The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.
Holbech JV; Otto M; Bach FW; Jensen TS; Sindrup SH
Eur J Pain; 2011 Jul; 15(6):608-14. PubMed ID: 21183370
[TBL] [Abstract][Full Text] [Related]
33. Online movement control in multiple sclerosis patients with tremor: effects of tendon vibration.
Feys P; Helsen WF; Verschueren S; Swinnen SP; Klok I; Lavrysen A; Nuttin B; Ketelaer P; Liu X
Mov Disord; 2006 Aug; 21(8):1148-53. PubMed ID: 16700031
[TBL] [Abstract][Full Text] [Related]
34. Separate episodes of delirium associated with levetiracetam and amiodarone treatment in an elderly woman.
Foley KT; Bugg KS
Am J Geriatr Pharmacother; 2010 Apr; 8(2):170-4. PubMed ID: 20439066
[TBL] [Abstract][Full Text] [Related]
35. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study.
Striano P; Manganelli F; Boccella P; Perretti A; Striano S
Mov Disord; 2005 Dec; 20(12):1610-4. PubMed ID: 16078205
[TBL] [Abstract][Full Text] [Related]
36. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
[TBL] [Abstract][Full Text] [Related]
37. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Van Der Walt A; Sung S; Spelman T; Marriott M; Kolbe S; Mitchell P; Evans A; Butzkueven H
Neurology; 2012 Jul; 79(1):92-9. PubMed ID: 22753445
[TBL] [Abstract][Full Text] [Related]
38. Levetiracetam improves intention tremor in fragile x-associated tremor/ataxia syndrome.
Saponara R; Greco S; Proto G; Trubia T; Domina E
Clin Neuropharmacol; 2009; 32(1):53-4. PubMed ID: 19471185
[TBL] [Abstract][Full Text] [Related]
39. Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.
Gironell A; Kulisevsky J; Pascual-Sedano B; Flamarich D
Mov Disord; 2006 Apr; 21(4):441-5. PubMed ID: 16229019
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of levetiracetam in Huntington disease.
de Tommaso M; Di Fruscolo O; Sciruicchio V; Specchio N; Cormio C; De Caro MF; Livrea P
Clin Neuropharmacol; 2005; 28(6):280-4. PubMed ID: 16340384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
